Rahul M. Kohli, MD, PhD

Infectious Diseases
Accepting new patients
Sees patients age 18 and up
Call 800-789-7366
Headshot of Rahul M. Kohli, MD, PhD
Penn Medicine Provider

About me

  • Francis C. Wood Associate Professor in Medicine II
  • Associate Professor of Medicine in Biochemistry and Biophysics

My education and training

  • Medical School: Harvard Medical School
  • Residency: University of Pennsylvania Health System
  • Fellowship: Johns Hopkins Hospital

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Kohli is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Schutsky EK, DeNizio JE, Hu P, Liu MY, Nabel CS, Fabyanic EB, Hwang Y, Bushman FD, Wu H, Kohli RM Nondestructive, base-resolution sequencing of 5-hydroxymethylcytosine using a DNA deaminase , Nature Biotech, 8(10): 2018,1083–1090

DeNizio JE, Liu MY, Leddin EM, Cisneros GA, Kohli RM Selectivity and Promiscuity in TET-Mediated Oxidation of 5-Methylcytosine in DNA and RNA , Biochemistry, 58(5): 2019,411-421

Samuels AN, Roggiani M, Zhu J, Goulian M, Kohli RM The SOS Response Mediates Sustained Colonization of the Mammalian Gut , Infection and Immunity, 87(2): 2019,e00711-18

Ghanty U, DeNizio JE, Liu MY, Kohli RM Exploiting Substrate Promiscuity to Develop Activity-Based Probes for TET Family Enzymes , J Am Chem Soc, 140(50): 2018,17329-17332

Selwood T, Larsen BJ, Mo CY, Culyba MJ, Hostetler ZM, Kohli RM, Reitz AB, Baugh SDP. Advancement of the 5-Amino-1-(Carbamoylmethyl)-1H-1,2,3-Triazole-4-Carboxamide Scaffold to Disarm the Bacterial SOS Response. , Frontiers in Microbiology, 9(1): 2018,2961

Hrit J, Goodrich L, Li C, Wang BA, Nie J, Cui X, Martin EA, Simental E, Fernandez J, Liu MY, Nery JR, Castanon R, Kohli RM, Tretyakova N, He C, Ecker JR, Goll M, Panning B OGT binds a conserved C-terminal domain of TET1 to regulate TET1 activity and function in development , Elife, 7(1): 2018,e34870

Hostetler ZM, Ferrie JJ, Bornstein MR, Sungwienwong I, Petersson EJ, Kohli RM Systematic Evaluation of Soluble Protein Expression Using a Fluorescent Unnatural Amino Acid Reveals No Reliable Predictors of Tolerability , ACS Chem Bio, 13(10): 2018,2855-2861

Sungwienwong I, Ferrie JJ, Jun JV, Liu C, Barrett TM, Hostetler ZM, Ieda N, Hendricks A, Muthusamy AK, Kohli RM, Chenoweth DM, Petersson GA, Petersson EJ Improving the fluorescent probe acridonylalanine through a combination of theory and experiment , J Phys Org Chen, 31(8): 2018,e3813

Fraietta JA, Nobles CL, Sammons MA, Lundh S, Carty SA, Reich TJ, Cogdill AP, Morrissette JJD, DeNizio JE, Reddy S, Hwang Y, Gohil M, Kulikovskaya I, Nazimuddin F, Gupta M, Chen F, Everett JK, Alexander KA, Lin-Shiao E, Gee MH, Liu X, Young RM, Ambrose D, Wang Y, Xu J, Jordan MS, Marcucci KT, Levine BL, Garcia KC, Zhao Y, Kalos M, Porter DL, Kohli RM, Lacey SF, Berger SL, Bushman FD, June CH, Melenhorst JJ Disruption of TET2 Promotes the Therapeutic Efficacy of CD19-targeted T cells , Nature, 558(7709): 2018,307-312

View all publications